Developer docs
API playgroundTry for free, no card

Search company profiles

Bionos Biotech

Full company profile

uuid000xqpv

Namestring
Bionos Biotech
Legal namestring
Bionos Biotech S.L.
Websiteurl
bionos.es
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Bionos Biotech S.L. is a Valencia-based contract research organization (CRO) founded in January 2013 as a spin-off from the Developmental Biology Laboratory at Hospital La Fe. The company designs and executes efficacy studies for the cosmetic and food-nutraceutical industries, using in vitro, ex vivo, and in vivo methodologies, and operates from the Biopolo at Hospital Universitario y Politécnico La Fe. Its portfolio spans cosmetic efficacy testing (anti-aging, depigmentation, anti-pollution, UV-IR-HEV protection, hair care, anti-inflammatory, epigenetic, antioxidant, firming, regeneration, skin penetration studies), food/nutraceutical clinical trials (functional food, toxicology, metabolism, enzymatic activity, regenerative capacity), and pharmaceutical dermatological actives research.

Bionos differentiates through proprietary technical platforms — including the Bio Blue Light Scanner for high-resolution cutaneous surface evaluation, the Bio3D Structured-Light Scanner for volumetric clinical analysis, a validated Medaka (Oryzias latipes) fish model platform for antioxidant and anti-aging screening, and skin microbiome analysis — supported by peer-reviewed publications and partnerships with IIS-La Fe, CIPF, UPV, Isdin, Mibelle Biochemistry, and others. The company is ISO 9001:2015 certified, registered as a Sanitary Center (No. 22043) with the Generalitat Valenciana, and holds EIBT and Pyme Innovadora accreditations.

The business model is quote-based professional services revenue from B2B clients, with 135+ international customers (50% of 2019 revenue from international billing), reach through trade shows (IFSCC, In-Cosmetics Global/Asia, Cosmetorium, Supplier's Day NYC), and direct commercial contact. In 2020 the company launched a Testing by Bionos sub-brand for COVID-19 PCR and antibody testing services, and it participates in EU-funded consortia (PHOCNOSIS, AlgaeCeuticals, BRYOMOLECULES, EDUALGAE, SINUé). Funding has been limited to public grants (CDTI NEOTEC 2015, Valencia Emprende SEED, IVACE 2022) with no disclosed institutional venture capital.

Short descriptiontext

Bionos Biotech is a Valencia-based CRO (founded 2013, Hospital La Fe spin-off) that runs in vitro, ex vivo, and in vivo efficacy studies for cosmetic, food, and nutraceutical clients internationally, using proprietary imaging scanners and validated Medaka fish models.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersValencia, Spain
HQ citystring
Valencia
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract research services, cosmetic efficacy testing, food clinical trials, in vitro bioassays, biological diagnostic testing
Industry5 codes
PRIMARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
SECONDARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
NAICS code1 code
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Contract Research Organization (Cosmetic & Food Efficacy Testing)
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Efficacy Studies for Cosmetics
TypeProfessional Services
Description

Contract research services providing efficacy testing for cosmetic products and ingredients. Services include anti-aging, depigmentation, anti-pollution, UV-IR-HEV protection, hair care, anti-inflammatory, epigenetic, antioxidant, firming, regeneration, and skin penetration studies.

bionos.es
2Clinical Trials for Food Industry
TypeProfessional Services
Description

Clinical efficacy testing services for functional foods, toxicology, metabolism, enzymatic activity, and regenerative capacity studies.

bionos.es
3COVID-19 Diagnostic Testing (Testing by Bionos)
TypeProfessional Services
Description

PCR and antibody testing services for public and private entities including regional health authorities, companies, nursing homes, hospitals, health insurance funds, and schools. Performed 200-400 daily analyses during pandemic.

bionos.es
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Bionos Biotech is a Contract Research Organization (CRO) specialized in efficacy testing for the cosmetic and food-nutraceutical industries. The company designs and develops bioassays using in vitro, ex vivo, and in vivo methodologies to scientifically validate product claims for anti-aging, depigmentation, anti-pollution, UV-IR-HEV protection, hair care, anti-inflammatory, antioxidant, firming, regeneration, and skin penetration applications. It also operates a Testing by Bionos sub-brand for COVID-19 diagnostic testing services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 1,750+ products and ingredients tested
+3 more records
Product overview1 text field

Bionos Biotech is a Contract Research Organization (CRO) offering a comprehensive portfolio of efficacy studies for the cosmetic and food industries. The core offering consists of bioassays conducted through three methodological approaches—in vitro, ex vivo, and in vivo—spanning cosmetic efficacy testing (anti-wrinkle, depigmenting, UV protection, hair care, antioxidant, and skin penetration studies) and food clinical trials (functional food, toxicology, metabolism). Proprietary technology platforms include the Bio Blue Light Scanner for high-resolution skin imaging and the Bio3D Structured-Light Scanner for volumetric analysis. The company operates a sub-brand, Testing by Bionos, for COVID-19 diagnostic services. Bionos also participates in collaborative EU-funded research projects including BRYOMOLECULES (bryophyte bioactive compounds) and EDUALGAE (microalgae-based sweeteners).

Product and service6 records
1In Vitro Bioassays (Bioensayos In Vitro)
CategoryContract Research / Efficacy Testing
Description

Laboratory-based efficacy studies using in vitro methods for cosmetic and food industry products, analyzing biological responses in controlled environments outside living organisms. Serves cosmetic and food companies requiring molecular-level and cellular efficacy data.

2Ex Vivo Bioassays (Bioensayos Ex Vivo)
CategoryContract Research / Efficacy Testing
Description

Efficacy testing using living tissue or cells maintained outside the body, bridging in vitro and in vivo approaches for product validation. Serves cosmetic and food companies seeking intermediate-complexity biological testing.

3In Vivo Bioassays (Bioensayos In Vivo)
CategoryContract Research / Clinical Testing
Description

Clinical efficacy studies conducted with human volunteers to validate cosmetic and food product claims under real-use conditions. Serves cosmetic and food companies seeking human clinical evidence.

4Cosmetic Efficacy Studies (Ensayos Cosmética)
CategoryContract Research / Cosmetic Testing
Description

Comprehensive efficacy testing services for cosmetic products including anti-wrinkle, depigmenting, anti-pollution, UV-IR-HEV protection, anti-aging, hair care, anti-inflammatory, epigenetic, antioxidant, firming, regeneration, and skin penetration studies. Serves cosmetic and personal care companies.

5Food Clinical Trials (Ensayos Alimentación)
CategoryContract Research / Food Clinical Trials
Description

Clinical trials and efficacy studies for the food industry including functional food, toxicology, metabolism, enzymatic activity, and regenerative capacity assessments. Serves food and beverage companies requiring health-claim validation.

6Testing by Bionos (COVID-19 Diagnostic Testing)
CategoryDiagnostic Testing Services
Description

Dedicated COVID-19 testing service brand offering PCR and antibody tests with response times under 24 hours. Serves public health authorities, companies, nursing homes, hospitals, health insurance funds, and schools. Performed 200-400 daily analyses during the pandemic.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership17 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-23
Description

Research project for developing natural sweeteners from lichenic microalgae as sugar substitutes for bakery and pastry products.

2BRYOMOLECULES Consortium (EU)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-18
Description

EU-funded initiative for systematic search of bioactive compounds from European bryophytes (mosses and liverworts) for sustainable cosmetic and pharmaceutical applications. Documentary released in 2025.

bionos.es
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-24
Description

Surgical planning solutions for brain tumors using identity habitats of gliomas enabling intraoperative immunotherapeutic treatment decisions.

4Eurofins Cosmetics & Personal Care
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-05-02
Description

Network collaboration with Eurofins, described as having 30+ years of experience and leadership in cosmetics and personal care testing, for expanded testing capabilities and services.

bionos.es
5Phenocell
Strategic tierSecondaryTypeTechnology or IntegrationAnnounced on2022-05-02
Description

Collaboration in new venture combining Phenocell's capabilities with Bionos testing expertise.

bionos.es
Strategic tierSecondaryTypeTechnology or IntegrationAnnounced on2022-05-02
Description

Partnership in new testing venture combining CTIBiotech's 3D tissue models with Bionos bioassay expertise.

7Hospital La Fe / Instituto de Salud Carlos III
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-09-17
Description

Collaboration on COVID-19 epidemiological prevalence project during the pandemic.

bionos.es
8Mibelle Biochemistry
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-09-20
Description

Collaboration to functionally validate MossCellTech No.1 active ingredient, which won In-Cosmetics Global Innovation Award 2018. Article published in Industria Cosmética magazine.

bionos.es
9AlgaeCeuticals (RISE H2020)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-05-02
Description

EU RISE H2020 project exploring microalgae and cyanobacteria metabolites for beneficial applications in cosmetics and pharmaceuticals.

bionos.es
10Instituto de Investigación Sanitaria del Hospital La Fe (IIS-La Fe)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2017-10-30
Description

Collaboration for antioxidant and anti-aging research using Medaka fish model. Joint publication in Rejuvenation Research demonstrating cocoa extract's protective effects against oxidative stress.

bionos.es
11Centro de Investigación Príncipe Felipe (CIPF)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2017-10-30
Description

Trilateral collaboration with IIS-La Fe for research on cocoa extract antioxidant and anti-aging properties, validating Medaka as screening platform.

bionos.es
12Isdin
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2017-10-19
Description

Collaboration to demonstrate antioxidant capacity of topical melatonin using in vitro Medaka model, measuring gene expression of antioxidant enzymes (SOD1, CAT, Nrf2, GPx1).

bionos.es
13Beauty Cluster de Barcelona
Strategic tierSecondaryTypeChannel Partner/ Reseller/ DistributorAnnounced on2017-01-10
Description

Cluster membership as first member joined in 2017, providing networking and ecosystem integration within Barcelona's beauty industry cluster.

bionos.es
Strategic tierSecondaryTypeChannel Partner/ Reseller/ DistributorAnnounced on2015-09-28
Description

Cluster membership as associated company in BIOVAL, the BIO sector cluster of the Valencian Community, for industry networking and collaboration.

15PHOCNOSIS Consortium (EU H2020)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2015-09-19
Description

EU Horizon 2020 project for early diagnosis of cardiovascular diseases through portable device. Bionos participates in functional validation of the device. Led by UPV.

bionos.es
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2015-09-19
Description

Multiple collaborations including PHOCNOSIS project led by UPV's Nanophotonic Technology Center (NTC) and joint research initiatives.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2015-02-28
Description

Joint venture agreement to research potential cosmetic ingredients and dermatological actives with biological action such as skin regeneration, repair, anti-aging and antioxidant effects.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Eurofins Cosmetics & Personal Care
TypeBroad incumbent
Description

Global leader in cosmetics and personal care testing with 30+ years of experience. Already a network partner of Bionos and the dominant reference point in the segment where Bionos operates; directly comparable for efficacy, safety, and claim-substantiation services.

TypeBroad incumbent
Description

Global TIC (testing, inspection, certification) major offering cosmetic product testing, clinical trials, and claim substantiation services. Comparable to Bionos on service overlap but vastly larger in scale and geographic reach.

TypeBroad incumbent
Description

Multinational testing, inspection, and certification company with broad cosmetics and consumer products testing capabilities. Competes for the same enterprise R&D testing budgets as Bionos but at global scale.

4Bioalternatives
TypeDirect peer
Description

France-based CRO specializing in in vitro and ex vivo efficacy testing for cosmetic and pharmaceutical ingredients. Closest comparable in niche: same methodologies, similar customer base (ingredient suppliers and cosmetic brands) and similar size class.

5CeeTox
TypeDirect peer
Description

US-based CRO focused on in vitro toxicology and efficacy testing for cosmetics, personal care, and pharmaceutical clients. Comparable scope in cell-based assays, claim-substantiation studies, and ingredient screening.

TypeBroad incumbent
Description

Large global CRO with established safety assessment, bioanalysis, and research services for cosmetics, chemicals, and pharma. Adjacent to Bionos in endpoints and regulatory expertise but at substantially larger scale.

TypeEmerging player
Description

France-based CRO offering biomarker, omics, and bioassay services to cosmetics and nutrition clients. Comparable in technical approach (molecular readouts, skin biology) and emerging-segment positioning.

8SkinEthic / Episkin (L'Oréal)
TypeDirect peer
Description

Provider of reconstructed human skin models and in vitro testing services for cosmetic, chemical, and pharmaceutical industries. Comparable offering on reconstructed tissue assays and claim-substantiation testing.

TypeBroad incumbent
Description

Wider Eurofins group offering discovery, bioanalytical, and in vitro pharmacology services. Competes for early-stage cosmetic/pharma R&D budgets that overlap with Bionos's efficacy screening work.

10XCellR8
TypeDirect peer
Description

UK-based CRO providing non-animal efficacy and safety testing for cosmetics and chemicals, including in vitro bioassays and skin sensitization. Highly comparable service mix and target customer base (ethical beauty, ingredient suppliers).

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bionos Biotech

Contract Research Organization (Cosmetic & Food Efficacy Testing)bionos.es

Bionos Biotech is a Valencia-based CRO (founded 2013, Hospital La Fe spin-off) that runs in vitro, ex vivo, and in vivo efficacy studies for cosmetic, food, and nutraceutical clients internationally, using proprietary imaging scanners and validated Medaka fish models.

What Bionos Biotech does

Bionos Biotech S.L. is a Valencia-based contract research organization (CRO) founded in January 2013 as a spin-off from the Developmental Biology Laboratory at Hospital La Fe. The company designs and executes efficacy studies for the cosmetic and food-nutraceutical industries, using in vitro, ex vivo, and in vivo methodologies, and operates from the Biopolo at Hospital Universitario y Politécnico La Fe. Its portfolio spans cosmetic efficacy testing (anti-aging, depigmentation, anti-pollution, UV-IR-HEV protection, hair care, anti-inflammatory, epigenetic, antioxidant, firming, regeneration, skin penetration studies), food/nutraceutical clinical trials (functional food, toxicology, metabolism, enzymatic activity, regenerative capacity), and pharmaceutical dermatological actives research.

Bionos differentiates through proprietary technical platforms — including the Bio Blue Light Scanner for high-resolution cutaneous surface evaluation, the Bio3D Structured-Light Scanner for volumetric clinical analysis, a validated Medaka (Oryzias latipes) fish model platform for antioxidant and anti-aging screening, and skin microbiome analysis — supported by peer-reviewed publications and partnerships with IIS-La Fe, CIPF, UPV, Isdin, Mibelle Biochemistry, and others. The company is ISO 9001:2015 certified, registered as a Sanitary Center (No. 22043) with the Generalitat Valenciana, and holds EIBT and Pyme Innovadora accreditations.

The business model is quote-based professional services revenue from B2B clients, with 135+ international customers (50% of 2019 revenue from international billing), reach through trade shows (IFSCC, In-Cosmetics Global/Asia, Cosmetorium, Supplier's Day NYC), and direct commercial contact. In 2020 the company launched a Testing by Bionos sub-brand for COVID-19 PCR and antibody testing services, and it participates in EU-funded consortia (PHOCNOSIS, AlgaeCeuticals, BRYOMOLECULES, EDUALGAE, SINUé). Funding has been limited to public grants (CDTI NEOTEC 2015, Valencia Emprende SEED, IVACE 2022) with no disclosed institutional venture capital.

Bionos Biotech firmographics

Firmographics
Name
Bionos Biotech
Legal name
Bionos Biotech S.L.
Website
https://bionos.es
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
Bionos Biotech is a Valencia-based CRO (founded 2013, Hospital La Fe spin-off) that runs in vitro, ex vivo, and in vivo efficacy studies for cosmetic, food, and nutraceutical clients internationally, using proprietary imaging scanners and validated Medaka fish models.
Ownership category
akta.pro rank

Bionos Biotech industry classification

Industry
Product category
Contract Research Organization (Cosmetic & Food Efficacy Testing)
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
SECONDARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGAAAD
Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity)
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs

Keywords

  • Contract research services
  • Cosmetic efficacy testing
  • Food clinical trials
  • In vitro bioassays
  • Biological diagnostic testing

Where Bionos Biotech is headquartered

Location

Headquarters

HQ city
Valencia
HQ country
Spain
HQ region
Europe

Offices2 records

Markets served

Bionos Biotech business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Efficacy Studies for Cosmetics: Contract research services providing efficacy testing for cosmetic products and ingredients. Services include anti-aging, depigmentation, anti-pollution, UV-IR-HEV protection, hair care, anti-inflammatory, epigenetic, antioxidant, firming, regeneration, and skin penetration studies.
  2. Clinical Trials for Food Industry: Clinical efficacy testing services for functional foods, toxicology, metabolism, enzymatic activity, and regenerative capacity studies.
  3. COVID-19 Diagnostic Testing (Testing by Bionos): PCR and antibody testing services for public and private entities including regional health authorities, companies, nursing homes, hospitals, health insurance funds, and schools. Performed 200-400 daily analyses during pandemic.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Bionos Biotech product offering

Product offering

Core offering

Bionos Biotech is a Contract Research Organization (CRO) specialized in efficacy testing for the cosmetic and food-nutraceutical industries. The company designs and develops bioassays using in vitro, ex vivo, and in vivo methodologies to scientifically validate product claims for anti-aging, depigmentation, anti-pollution, UV-IR-HEV protection, hair care, anti-inflammatory, antioxidant, firming, regeneration, and skin penetration applications. It also operates a Testing by Bionos sub-brand for COVID-19 diagnostic testing services.

Product overview

Bionos Biotech is a Contract Research Organization (CRO) offering a comprehensive portfolio of efficacy studies for the cosmetic and food industries. The core offering consists of bioassays conducted through three methodological approaches—in vitro, ex vivo, and in vivo—spanning cosmetic efficacy testing (anti-wrinkle, depigmenting, UV protection, hair care, antioxidant, and skin penetration studies) and food clinical trials (functional food, toxicology, metabolism). Proprietary technology platforms include the Bio Blue Light Scanner for high-resolution skin imaging and the Bio3D Structured-Light Scanner for volumetric analysis. The company operates a sub-brand, Testing by Bionos, for COVID-19 diagnostic services. Bionos also participates in collaborative EU-funded research projects including BRYOMOLECULES (bryophyte bioactive compounds) and EDUALGAE (microalgae-based sweeteners).

Differentiator

Problem solved

Functional benefit

Products and services

  • In Vitro Bioassays (Bioensayos In Vitro) Laboratory-based efficacy studies using in vitro methods for cosmetic and food industry products, analyzing biological responses in controlled environments outside living organisms. Serves cosmetic and food companies requiring molecular-level and cellular efficacy data.
  • Ex Vivo Bioassays (Bioensayos Ex Vivo) Efficacy testing using living tissue or cells maintained outside the body, bridging in vitro and in vivo approaches for product validation. Serves cosmetic and food companies seeking intermediate-complexity biological testing.
  • In Vivo Bioassays (Bioensayos In Vivo) Clinical efficacy studies conducted with human volunteers to validate cosmetic and food product claims under real-use conditions. Serves cosmetic and food companies seeking human clinical evidence.
  • Cosmetic Efficacy Studies (Ensayos Cosmética) Comprehensive efficacy testing services for cosmetic products including anti-wrinkle, depigmenting, anti-pollution, UV-IR-HEV protection, anti-aging, hair care, anti-inflammatory, epigenetic, antioxidant, firming, regeneration, and skin penetration studies. Serves cosmetic and personal care companies.
  • Food Clinical Trials (Ensayos Alimentación) Clinical trials and efficacy studies for the food industry including functional food, toxicology, metabolism, enzymatic activity, and regenerative capacity assessments. Serves food and beverage companies requiring health-claim validation.
  • Testing by Bionos (COVID-19 Diagnostic Testing) Dedicated COVID-19 testing service brand offering PCR and antibody tests with response times under 24 hours. Serves public health authorities, companies, nursing homes, hospitals, health insurance funds, and schools. Performed 200-400 daily analyses during the pandemic.

Quantifiable outcome

  • 1,750+ products and ingredients tested
  • +3 more outcomes

Companies that use Bionos Biotech

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Bionos Biotech technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Bionos Biotech partnerships and signals

Strategic signal

Partnerships

17 partnerships are on record, tiered core and secondary.

  • EDUALGAE ProjectcoreStrategic or Co-development Partner · 23 March 2026Research project for developing natural sweeteners from lichenic microalgae as sugar substitutes for bakery and pastry products.
  • BRYOMOLECULES Consortium (EU)coreStrategic or Co-development Partner · 18 September 2025EU-funded initiative for systematic search of bioactive compounds from European bryophytes (mosses and liverworts) for sustainable cosmetic and pharmaceutical applications. Documentary released in 2025.
  • SINUÉ ProjectcoreStrategic or Co-development Partner · 24 January 2025Surgical planning solutions for brain tumors using identity habitats of gliomas enabling intraoperative immunotherapeutic treatment decisions.
  • Eurofins Cosmetics & Personal CarecoreTechnology or Integration · 2 May 2022Network collaboration with Eurofins, described as having 30+ years of experience and leadership in cosmetics and personal care testing, for expanded testing capabilities and services.
  • PhenocellsecondaryTechnology or Integration · 2 May 2022Collaboration in new venture combining Phenocell's capabilities with Bionos testing expertise.
  • CTIBiotechsecondaryTechnology or Integration · 2 May 2022Partnership in new testing venture combining CTIBiotech's 3D tissue models with Bionos bioassay expertise.
  • Hospital La Fe / Instituto de Salud Carlos IIIcoreStrategic or Co-development Partner · 17 September 2020Collaboration on COVID-19 epidemiological prevalence project during the pandemic.
  • Mibelle BiochemistrycoreStrategic or Co-development Partner · 20 September 2018Collaboration to functionally validate MossCellTech No.1 active ingredient, which won In-Cosmetics Global Innovation Award 2018. Article published in Industria Cosmética magazine.
  • AlgaeCeuticals (RISE H2020)coreStrategic or Co-development Partner · 2 May 2018EU RISE H2020 project exploring microalgae and cyanobacteria metabolites for beneficial applications in cosmetics and pharmaceuticals.
  • Instituto de Investigación Sanitaria del Hospital La Fe (IIS-La Fe)coreStrategic or Co-development Partner · 30 October 2017Collaboration for antioxidant and anti-aging research using Medaka fish model. Joint publication in Rejuvenation Research demonstrating cocoa extract's protective effects against oxidative stress.
  • Centro de Investigación Príncipe Felipe (CIPF)coreStrategic or Co-development Partner · 30 October 2017Trilateral collaboration with IIS-La Fe for research on cocoa extract antioxidant and anti-aging properties, validating Medaka as screening platform.
  • IsdincoreStrategic or Co-development Partner · 19 October 2017Collaboration to demonstrate antioxidant capacity of topical melatonin using in vitro Medaka model, measuring gene expression of antioxidant enzymes (SOD1, CAT, Nrf2, GPx1).
  • Beauty Cluster de BarcelonasecondaryChannel Partner/ Reseller/ Distributor · 10 January 2017Cluster membership as first member joined in 2017, providing networking and ecosystem integration within Barcelona's beauty industry cluster.
  • BIOVALsecondaryChannel Partner/ Reseller/ Distributor · 28 September 2015Cluster membership as associated company in BIOVAL, the BIO sector cluster of the Valencian Community, for industry networking and collaboration.
  • PHOCNOSIS Consortium (EU H2020)coreStrategic or Co-development Partner · 19 September 2015EU Horizon 2020 project for early diagnosis of cardiovascular diseases through portable device. Bionos participates in functional validation of the device. Led by UPV.
  • Universitat Politècnica de València (UPV)coreStrategic or Co-development Partner · 19 September 2015Multiple collaborations including PHOCNOSIS project led by UPV's Nanophotonic Technology Center (NTC) and joint research initiatives.
  • Inkemia IUCTcoreStrategic or Co-development Partner · 28 February 2015Joint venture agreement to research potential cosmetic ingredients and dermatological actives with biological action such as skin regeneration, repair, anti-aging and antioxidant effects.

Scale indicators13 records

Recent moves7 records

Expansion highlights6 records

Bionos Biotech competitors and assessment

Company assessment

Broad incumbents

  • Eurofins Cosmetics & Personal Care: Global leader in cosmetics and personal care testing with 30+ years of experience. Already a network partner of Bionos and the dominant reference point in the segment where Bionos operates; directly comparable for efficacy, safety, and claim-substantiation services.
  • SGS: Global TIC (testing, inspection, certification) major offering cosmetic product testing, clinical trials, and claim substantiation services. Comparable to Bionos on service overlap but vastly larger in scale and geographic reach.
  • Intertek: Multinational testing, inspection, and certification company with broad cosmetics and consumer products testing capabilities. Competes for the same enterprise R&D testing budgets as Bionos but at global scale.
  • Charles River Laboratories: Large global CRO with established safety assessment, bioanalysis, and research services for cosmetics, chemicals, and pharma. Adjacent to Bionos in endpoints and regulatory expertise but at substantially larger scale.
  • Eurofins CDMO / Eurofins Discovery: Wider Eurofins group offering discovery, bioanalytical, and in vitro pharmacology services. Competes for early-stage cosmetic/pharma R&D budgets that overlap with Bionos's efficacy screening work.

Direct peers

  • Bioalternatives: France-based CRO specializing in in vitro and ex vivo efficacy testing for cosmetic and pharmaceutical ingredients. Closest comparable in niche: same methodologies, similar customer base (ingredient suppliers and cosmetic brands) and similar size class.
  • CeeTox: US-based CRO focused on in vitro toxicology and efficacy testing for cosmetics, personal care, and pharmaceutical clients. Comparable scope in cell-based assays, claim-substantiation studies, and ingredient screening.
  • SkinEthic / Episkin (L'Oréal): Provider of reconstructed human skin models and in vitro testing services for cosmetic, chemical, and pharmaceutical industries. Comparable offering on reconstructed tissue assays and claim-substantiation testing.
  • XCellR8: UK-based CRO providing non-animal efficacy and safety testing for cosmetics and chemicals, including in vitro bioassays and skin sensitization. Highly comparable service mix and target customer base (ethical beauty, ingredient suppliers).

Emerging players

  • Phylogene: France-based CRO offering biomarker, omics, and bioassay services to cosmetics and nutrition clients. Comparable in technical approach (molecular readouts, skin biology) and emerging-segment positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Bionos Biotech social profiles

Digital presence

Bionos Biotech compliance and trust

Trust signal

Compliance4 records

Bionos Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bionos Biotech leadership team

Management profile

Number of profiles

Profiles2 records

Bionos Biotech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bionos Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bionos Biotech

What does Bionos Biotech do?

Bionos Biotech is a Contract Research Organization (CRO) specialized in efficacy testing for the cosmetic and food-nutraceutical industries. The company designs and develops bioassays using in vitro, ex vivo, and in vivo methodologies to scientifically validate product claims for anti-aging, depigmentation, anti-pollution, UV-IR-HEV protection, hair care, anti-inflammatory, antioxidant, firming, regeneration, and skin penetration applications. It also operates a Testing by Bionos sub-brand for COVID-19 diagnostic testing services.

Is Bionos Biotech a public or private company?

Bionos Biotech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Bionos Biotech founded?

Bionos Biotech was founded in 2013. It employs 11 to 50 people.

Where is Bionos Biotech based?

Bionos Biotech is headquartered in Valencia, Spain, in the Europe region.

How does Bionos Biotech make money?

Three revenue lines are on record. Efficacy Studies for Cosmetics are the primary driver. The others are clinical Trials for Food Industry and COVID-19 Diagnostic Testing (Testing by Bionos).

Who are Bionos Biotech's main competitors?

Broad incumbents on record are Eurofins Cosmetics & Personal Care, SGS, Intertek, Charles River Laboratories and Eurofins CDMO / Eurofins Discovery. Direct peers are Bioalternatives, CeeTox, SkinEthic / Episkin (L'Oréal) and XCellR8. Phylogene is listed as an emerging player.

Does Bionos Biotech have an API?

No public API is recorded for Bionos Biotech.

What industry is Bionos Biotech in?

Bionos Biotech's product category is Contract Research Organization (Cosmetic & Food Efficacy Testing). Its primary akta.pro industry code is HLAGADAH, Cell-Based & Potency Assays (Bioassays), with a secondary code of HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Cosmetics BusinessSpanish CRO Bionos Bitoech remains open and launches new studies to fight against covid-19Bionos Biotech, a Spanish cosmetic and food-nutraceutical testing lab, remains open and has launched new bioassays to validate antimicrobial and sanitizing claims. The company also developed a Hand-Washing Test and is preparing PCR and antibody tests for SARS-CoV-2 detection.Cosmetics BusinessBionos Biotech introduces new anti-acne efficacy testing at Suppliers' DayBionos Biotech introduced a new anti-acne efficacy testing system at Suppliers' Day in New York, based on its existing Bio3D Structured-light Scanner technology. The 3D scanner captures 290 images per second and analyzes skin parameters like pimple area and height. The company plans to expand its cosmetic testing services from Europe to Asia and the United States.Cosmetics BusinessSpanish CRO Bionos Biotech presents at in-cosmetics globalBionos Biotech will present at Incosmetics Global in Paris from April 2-4, showcasing its Bio3D Structured-light Scanner and Bio Blue Light Scanner for in vivo efficacy testing. The company aims to introduce these technologies to new clients, following successful use by international clients in 2018.Cosmetics BusinessBionos Biotech successfully exhibited its new R&D testing services at in-cosmetics Paris 2019Bionos Biotech exhibited its new R&D testing services at in-cosmetics Paris 2019, holding over 40 pre-scheduled meetings and attracting 100+ visitors. The company is preparing for Supplier's Day in New York in May to expand into the North American market.Cosmetics BusinessBionos Biotech to exhibit its portfolio of efficacy studies at in-cosmetics 2017Bionos Biotech will exhibit its portfolio of efficacy studies at In-Cosmetics London 2017, including over 80 studies on UV protection, antioxidant capacity, and other claims. The company, which received the Innovate SME seal, will occupy stand DD54 to showcase its assays globally.Cosmetics BusinessBionos Biotech at in-cosmetics LondonBionos Biotech's Sales & Development Manager David González and Scientific Director José Luis Mullor represented the company at In-Cosmetics London for the first time, speaking with over 50 potential clients. The company, in its fifth year, doubled its turnover in 2016 and plans to expand internationally after the fair. It will also attend Cosmetorium in Barcelona in October.Cosmetics BusinessBionos Biotech increases its turnover and will be present at Cosmetorium BarcelonaBionos Biotech, a cosmetics efficacy testing company, increased its turnover by 36% in the first half of 2017, citing expanded international presence and client consolidation. The company will exhibit its portfolio at Cosmetorium Barcelona on October 3-4. Management expects the second half to match the first, with year-end growth above 40%.Cosmetics BusinessBionos Biotech reaches 1,000 tested products and closes 2017 with a 45% increase in turnoverBionos Biotech, a Valencian efficacy-testing company, reached 1,000 tested products in December 2017 and closed the year with a 45% turnover increase. The company performed 200 new studies, exceeding its 40% growth target, and plans to attend In-Cosmetics Global Amsterdam, Cosmetorium Barcelona, and In-Cosmetics Asia in 2018.Cosmetics BusinessBionos Biotech to present at in-cosmetics Global AmsterdamBionos Biotech will present at in-cosmetics Global Amsterdam on April 17-19 at stand C318B in Hall 7. The company will showcase new in vitro anti-pollution and hair growth studies, plus in vivo assays, to meet clients and potential partners.Cosmetics BusinessBionos Biotech to exhibit its new R&D bioassays portfolioBionos Biotech will exhibit its R&D bioassays portfolio at In-Cosmetics Asia Bangkok and Cosmetorium Barcelona. The company reported over 20% growth in the first half of 2018 and expects near 25% annual growth for 2018. The exhibitions aim to attract new clients and meet existing ones.